RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392 | -58.9% | 836,017 | -3.6% | 0.00% | 0.0% |
| Q2 2023 | $954 | -10.8% | 867,217 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $1,069 | -21.2% | 898,717 | -1.2% | 0.00% | -50.0% |
| Q4 2022 | $1,356 | -99.9% | 909,817 | -5.0% | 0.00% | 0.0% |
| Q3 2022 | $1,561,000 | +89.9% | 957,932 | -7.3% | 0.00% | +100.0% |
| Q2 2022 | $822,000 | -55.2% | 1,033,400 | +1.3% | 0.00% | -50.0% |
| Q1 2022 | $1,836,000 | -7.3% | 1,020,000 | -11.9% | 0.00% | 0.0% |
| Q4 2021 | $1,981,000 | -20.2% | 1,158,200 | -3.9% | 0.00% | -33.3% |
| Q3 2021 | $2,482,000 | -6.6% | 1,204,988 | +4.8% | 0.00% | 0.0% |
| Q2 2021 | $2,657,000 | -22.4% | 1,150,273 | -6.2% | 0.00% | -25.0% |
| Q1 2021 | $3,422,000 | -13.0% | 1,226,375 | -11.1% | 0.00% | 0.0% |
| Q4 2020 | $3,932,000 | +27.9% | 1,379,785 | -5.7% | 0.00% | +33.3% |
| Q3 2020 | $3,074,000 | -39.7% | 1,463,888 | +30.6% | 0.00% | -25.0% |
| Q2 2020 | $5,101,000 | -49.3% | 1,121,100 | -9.0% | 0.00% | -60.0% |
| Q1 2020 | $10,061,000 | -46.1% | 1,231,400 | +20.9% | 0.01% | -28.6% |
| Q4 2019 | $18,676,000 | +97.6% | 1,018,862 | +19.4% | 0.01% | +75.0% |
| Q3 2019 | $9,451,000 | +20.8% | 853,000 | +10.9% | 0.01% | +14.3% |
| Q2 2019 | $7,824,000 | +79.9% | 769,300 | +3.7% | 0.01% | +75.0% |
| Q1 2019 | $4,349,000 | +0.3% | 742,200 | +21.5% | 0.00% | -20.0% |
| Q4 2018 | $4,337,000 | +27.0% | 610,800 | +27.1% | 0.01% | +25.0% |
| Q3 2018 | $3,416,000 | -42.2% | 480,500 | -35.4% | 0.00% | +33.3% |
| Q2 2018 | $5,906,000 | +47.9% | 743,900 | +105.2% | 0.00% | -25.0% |
| Q1 2018 | $3,992,000 | +253.6% | 362,600 | +197.2% | 0.00% | +300.0% |
| Q4 2017 | $1,129,000 | +27.1% | 122,000 | +23.4% | 0.00% | 0.0% |
| Q3 2017 | $888,000 | +25.8% | 98,900 | -1.5% | 0.00% | 0.0% |
| Q2 2017 | $706,000 | +27.2% | 100,400 | +58.1% | 0.00% | 0.0% |
| Q1 2017 | $555,000 | +275.0% | 63,500 | +245.1% | 0.00% | – |
| Q4 2016 | $148,000 | -48.3% | 18,400 | -43.2% | 0.00% | -100.0% |
| Q3 2016 | $286,000 | – | 32,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |